general/monoclonal-antibodies-for-tumors

Surf Wiki
Cetuximab (1) Indatuximab ravtansine (1) Olaratumab (1) Cetuximab (1) Mapatumumab (1) Mogamulizumab (1) Mapatumumab (1) Matuzumab (1) Panitumumab (1) Olaratumab (1) Ofatumumab (1) Bavituximab (1) Ibritumomab tiuxetan (1) Ibritumomab tiuxetan (1) Margetuximab (1) Elotuzumab (1) Mapatumumab (1) Olaratumab (1) Cetuximab (1) Lintuzumab (1) Ibritumomab tiuxetan (1) Mogamulizumab (1) Mapatumumab (1) Ibritumomab tiuxetan (1) Cetuximab (1) Olaratumab (1) Mogamulizumab (1) Mapatumumab (1) Ibritumomab tiuxetan (1) Cetuximab (1) Olaratumab (1) Nimotuzumab (1) Minretumomab (1) Alemtuzumab (1) Indatuximab ravtansine (1) Indatuximab ravtansine (1) Indatuximab ravtansine (1) Catumaxomab (1) Indatuximab ravtansine (1)
Sort: Quality Recent Views A-Z
Cetuximab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Indatuximab ravtansine

Chemical compound

general/monoclonal-antibodies-for-tumors
Olaratumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Cetuximab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Mapatumumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Mogamulizumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Mapatumumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Matuzumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Panitumumab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Olaratumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Ofatumumab

Medication

general/monoclonal-antibodies-for-tumors
Bavituximab

Chemical compound

general/monoclonal-antibodies-for-tumors
Ibritumomab tiuxetan

Radioimmunotherapy treatment

general/monoclonal-antibodies-for-tumors
Ibritumomab tiuxetan

Radioimmunotherapy treatment

general/monoclonal-antibodies-for-tumors
Margetuximab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Elotuzumab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Mapatumumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Olaratumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Cetuximab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Lintuzumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Ibritumomab tiuxetan

Radioimmunotherapy treatment

general/monoclonal-antibodies-for-tumors
Mogamulizumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Mapatumumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Ibritumomab tiuxetan

Radioimmunotherapy treatment

general/monoclonal-antibodies-for-tumors
Cetuximab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Olaratumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Mogamulizumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Mapatumumab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Ibritumomab tiuxetan

Radioimmunotherapy treatment

general/monoclonal-antibodies-for-tumors
Cetuximab

Pharmaceutical drug

general/monoclonal-antibodies-for-tumors
Olaratumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Nimotuzumab

Chemical compound

general/monoclonal-antibodies-for-tumors
Minretumomab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Alemtuzumab

Medication

general/monoclonal-antibodies-for-tumors
Indatuximab ravtansine

Chemical compound

general/monoclonal-antibodies-for-tumors
Indatuximab ravtansine

Chemical compound

general/monoclonal-antibodies-for-tumors
Indatuximab ravtansine

Chemical compound

general/monoclonal-antibodies-for-tumors
Catumaxomab

Monoclonal antibody

general/monoclonal-antibodies-for-tumors
Indatuximab ravtansine

Chemical compound

general/monoclonal-antibodies-for-tumors